Zimmer says it agreed with the European Commission to extend the EuroZone review of its pending, $13.4 billion acquisition of cross-town orthopedics rival Biomet.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Hfd1LR
Cap comentari:
Publica un comentari a l'entrada